Both in Pharmaceuticals
Aprea Therapeutics vs Alzamend Neuro
Over the past year APRE returned −66.0% and ALZN returned −50.3%; their daily moves had a correlation of 0.22.
APRE −66.0% ALZN −50.3%Growth of $1, one year, split-adjusted
| Metric | APRE | ALZN |
|---|---|---|
| Price | $0.4936 | $1.22 |
| Market cap | $6.2M | $5.9M |
| Today | −8.22% | +2.52% |
| 1 month | −34.2% | −29.5% |
| 6 months | −38.3% | +7.0% |
| Year to date | −42.1% | −33.0% |
| 1 year | −65.2% | −48.3% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 1,198.6× | — |
| Net cash | $41.2M | $7.6M |
| Dividend yield | — | — |
| Volatility (60d) | 95.7% | 77.2% |
| Short % of float | 5.9% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).